Jeffrey Weber Explains Organ-Specific Side Effects of Checkpoint Inhibitors


Dr. Jeffrey Weber describes the organ-specific side effects that can occur in a patient on checkpoint inhibitors.

Jeffrey Weber, MD, PhD, from NYU Langone Perlmutter Cancer Center explains the different organ-specific side effects that can occur when a patient is on checkpoint inhibitors. These toxicities can progress quickly and to fatal levels; therefore, patients need careful attention.

For example, an increase in pancreas function can present without any symptoms and requires monitoring of the patient’s lab results. Inflammation in the lungs can become pneumonitis, which can become fatal if not caught in time.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
© 2024 MJH Life Sciences

All rights reserved.